Publicaciones en colaboración con investigadores/as de Harvard Medical School (67)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. Chronic nSMase inhibition suppresses neuronal exosome spreading and sex-specifically attenuates amyloid pathology in APP knock-in Alzheimer's disease mice

    Neurobiology of Disease, Vol. 184

  2. Critical features of an in vitro intestinal absorption model to study the first key aspects underlying food allergen sensitization

    Comprehensive Reviews in Food Science and Food Safety, Vol. 22, Núm. 2, pp. 971-1005

  3. Elafibranor upregulates the EMT-inducer S100A4 via PPARβ/δ

    Biomedicine and Pharmacotherapy, Vol. 167

  4. Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing

    STAR Protocols, Vol. 4, Núm. 4

  5. In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities

    Blood cancer discovery, Vol. 4, Núm. 2, pp. 150-169

  6. Loss-of-function lesions impact B-cell development and fitness but are insufficient to drive CLL in mouse models

    Blood Advances, Vol. 7, Núm. 16, pp. 4514-4517

2022

  1. Structural basis for catalyzed assembly of the Sonic hedgehog–Patched1 signaling complex

    Developmental Cell, Vol. 57, Núm. 5, pp. 670-685.e8

2021

  1. A novel circulating microRNA for the detection of acute myocarditis

    New England Journal of Medicine, Vol. 384, Núm. 21, pp. 2014-2027

  2. ERK inhibitor LY3214996-based treatment strategies for RAS-driven lung cancer

    Molecular Cancer Therapeutics, Vol. 20, Núm. 4, pp. 641-654

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie

    Allergologie, Vol. 43, Núm. 7, pp. 255-271

  2. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 11, pp. 2764-2774

  3. High throughput single-cell detection of multiplex CRISPR-edited gene modifications

    Genome Biology, Vol. 21, Núm. 1

  4. Transient exposure to miR-203 enhances the differentiation capacity of established pluripotent stem cells

    EMBO Journal, Vol. 39, Núm. 16

2019

  1. Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF

    Cancer Cell, Vol. 35, Núm. 4, pp. 573-587.e6

  2. Dual PAK4-NAMPT inhibition impacts growth and survival, and increases sensitivity to DNA-damaging agents in Waldenstrom € macroglobulinemia

    Clinical Cancer Research, Vol. 25, Núm. 1, pp. 369-377

  3. Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies

    Cancer Cell, Vol. 36, Núm. 4, pp. 369-384.e13

  4. Pore-forming proteins from cnidarians and arachnids as potential biotechnological tools

    Toxins, Vol. 11, Núm. 6

  5. Priority Considerations for Medicinal Cannabis-Related Research

    Cannabis and Cannabinoid Research, Vol. 4, Núm. 3, pp. 139-157